ClinicalTrialsFinder

Mucopolysaccharidosis III-B Clinical Trials in Hiroshima

1 recruitingHiroshima, Japan

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB

Mucopolysaccharidosis III-B
JCR Pharmaceuticals Co., Ltd.10 enrolled3 locationsNCT06488924